SCHEMBL5899447

SCHEMBL5899447

O=C(CNS(=O)(=O)c1ccc(Oc2ccccc2)cc1)c1ccccc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 10/20 0.70
MMP1 P03956 6/20 0.70
ADAMTS4 O75173 4/20 0.70
MMP13 P45452 4/20 0.70
MMP14 P50281 4/20 0.70
ADAMTS5 Q9UNA0 4/20 0.70
MEP1B Q16820 1/20 0.70
KAT6A Q92794 2/20 0.56
CA2 P00918 6/20 0.55
CA9 Q16790 6/20 0.55
CA12 O43570 5/20 0.55
CA1 P00915 5/20 0.55
ERCC5 P28715 1/20 0.55
FEN1 P39748 1/20 0.55
BCL2L1 Q07817 2/20 0.53
MCL1 Q07820 2/20 0.53
GAA P10253 1/20 0.51
MMP12 P39900 1/20 0.51
MMP9 P14780 1/20 0.50
ADAM17 P78536 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2838364 0.91 MMP1 (0.64) MMP2MMP1ADAMTS4MMP13MMP14
SCHEMBL5899507 0.87 KAT6A (0.66) MMP2MMP1ADAMTS4MMP13MMP14
SCHEMBL5899544 0.86 KAT6A (0.58) MMP2MMP1MMP13MMP14MEP1B
SCHEMBL7247467 0.84 MMP2 (0.72) MMP2MMP1ADAMTS4MMP13MMP14
SCHEMBL23014361 0.82 KAT6A (0.58) MMP2MMP1MMP13MMP14MEP1B
SCHEMBL5899482 0.82 L3MBTL1 (0.60) MMP2MMP1MMP13MMP14MEP1B
SCHEMBL5320466 0.82 ALDH1A1 (0.60) MMP1KAT6ACA9CA12GAA
SCHEMBL5899737 0.82 MMP1 (0.63) MMP2MMP1ADAMTS4MMP13MMP14
SCHEMBL2842038 0.81 CASP3 (0.57) MMP2MMP1ADAMTS4MMP13MMP14
SCHEMBL7163404 0.80 MMP2 (0.62) MMP2MMP1ADAMTS4MMP13MMP14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060025445-A1 11-Beta HSD1 inhibitors WYETH 2006-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025445-A1 11-Beta HSD1 inhibitors HSD11B1, HSD11B2, HSD3B1 MMP2 1212/4885MMP1 369/4885ADAMTS4 397/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.